Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
Imunon
Watchlist
IMNN: Translational Data from OVATION 2 Presented
Equity Bottom-Up
347 Views
20 Jun 2025 17:00
Issuer-paid
On June 18, 2025, Imunon, Inc. (IMNN) announced the presentation of positive translational data from the Phase 2 OVATION 2 study of IMNN-001 at...
What is covered in the Full Insight:
Introduction to Imunon, Inc.
Translational Data from OVATION 2
Details of OVATION 3 Trial
Current Financial and Marketing Data
Outlook and Valuation Analysis
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »
IMNN: Translational Data from OVATION 2 Presented
IMNN: Momentum Continues with Presentations at ASCO and ESMO Gynaecological Cancers
IMNN: First Site Activated for Phase 3 OVATION 3 Trial
IMNN: Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer
IMNN: Phase 3 Ovarian Cancer Trial to get Underway in Mar 2025
Trending Collections
More »
Index Rebalance
India
Equity Bottom-Up
Unpaywalled Insights
Sell / Short Ideas
Equity Capital Markets (ECM)
South Korea
Japan
Event-Driven
US ECM
Trending Insights
More »
NSDL Vs CDSL: A Bottom-Up Comparison
SKT Foreign Room Heating Up — Time to Front-Run?
HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
HEW: Trade Deals & Fiscal Slippage
Meitu (1357 HK): AI-Driven Global Index Inclusion
Top Unpaywalled Insights
More »
[IO Technicals 2025/30] Iron Ore Rally Cools on Supply Surge, but Policy Hopes Keep Prices Afloat
New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum's Spike, MicroStrat...
Crypto Week Unleashes a Bitcoin Blitz and Sparks the Altcoin Catch-Up
The Bunny Returns: Playboy’s Market Comeback
HK Connect SOUTHBOUND Flows (To 18 July 2025); Volumes Strong, Net Buying Decent, Meituan Hot
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
IMNN: Translational Data from OVATION 2 Presented
20 Jun 2025
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.3
x